secwatch / observer
8-K filed October 6, 2023, 7:59 PM ET CIK 0001633070
other material confidence high sentiment negative materiality 0.75

Axcella Health Inc.: Nasdaq/NYSE listing notice — Axcella Health fails to regain Nasdaq market value compliance; hearing set; bid price deficiency cured

Axcella Health Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Axcella Health Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5450(b)(2)(A)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
market value
Rules
5450(b)(2)(C), 5450(b)(2)(A)
Exact text from the filing
October 3, 2023, we received written notice from the Staff of Nasdaq that we did not regain compliance with the MVPHS and MVLS listing rule requirements. We plan to submit our views with respect to these deficiencies to the Nasdaq’ Hearings Panel in writing no later than October 10, 2023. The Company was granted a hearing before the Panel, which is expected to take place on October 30, 2023. Such hearing will stay any further delisting action by the Staff at least pending the ultimate outcome of the hearing and the expiration of any extension that may be granted by the Panel. The Company’s com
View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001104659-23-107527
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.